Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Sensorion SAS (ALSEN) Stock Price & Analysis

ALSEN Stock Chart & Stats

€9.09€0.45(5.21%)
At close: 5:08 PM GMT+1
€5€10€153 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
EUR 8.50 - EUR 9.00
52-Week Range
EUR 5.25 - EUR 40.40
Previous Close
EUR 8.90
Volume
N/A
Average Volume (3M)
24.43K
Market Cap
EUR 87.32M
Enterprise Value
EUR 28.69M
Total Cash (Recent Filing)
EUR 88.49M
Total Debt (Recent Filing)
EUR 3.20M
Price to Earnings (P/E)
―
Beta
0.96
Next Earnings
Mar 18, 2027 (Est.)
EPS Estimate
-2.01
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Low Leverage

Low leverage and modest debt provide more financial flexibility than a highly indebted biotech, helping preserve options to fund research and absorb setbacks. This is a durable balance-sheet advantage, although it does not remove the need to finance ongoing losses.

Historical Revenue Expansion

Revenue expanded materially between 2020 and 2024, demonstrating that the company had previously built a larger revenue base before the latest disruption. That historical progress provides evidence of development or commercial traction that could support recovery if revenue-generating activity resumes.

Specialized Pipeline Focus

A specialized focus on inner-ear diseases gives Sensorion a clear therapeutic identity and concentrates R&D resources on defined unmet medical needs. Its pipeline approach, spanning preclinical research through clinical trials, creates multiple potential paths for future partnering or licensing.

Bears Say

Revenue Disruption

The fall to zero revenue represents a major break from the prior growth trajectory and increases uncertainty around the company’s ability to generate operating income. Without an established recurring revenue stream, funding future clinical development remains dependent on external sources.

Persistent Operating Losses

Large recurring operating and net losses show that Sensorion remains far from self-funding and has limited operating leverage at its current stage. Continued losses can consume financial resources, constrain investment choices, and make successful development outcomes increasingly important to long-term viability.

Sustained Cash Burn

Persistent negative operating and free cash flow means the business consumes cash while advancing its research programs rather than replenishing resources internally. This makes cash runway a central fundamental risk and increases reliance on equity, grants, licensing income, or other external funding.

Sensorion SAS News

ALSEN FAQ

What was Sensorion SAS’s price range in the past 12 months?
Sensorion SAS lowest stock price was €5.25 and its highest was €40.40 in the past 12 months.
What is Sensorion SAS’s market cap?
Sensorion SAS’s market cap is €87.32M.
When is Sensorion SAS’s upcoming earnings report date?
Sensorion SAS’s next earnings report is estimated for Mar 18, 2027 (not yet confirmed), which is in 136 days.
How were Sensorion SAS’s earnings last quarter?
Sensorion SAS released its earnings results on Sep 23, 2026. The company reported -€2.28 earnings per share for the quarter, missing the consensus estimate of -€1.39 by -€0.89.
Is Sensorion SAS overvalued?
According to Wall Street analysts Sensorion SAS’s price is currently Undervalued.
Does Sensorion SAS pay dividends?
Sensorion SAS does not currently pay dividends.
What is Sensorion SAS’s EPS estimate?
Sensorion SAS’s EPS estimate is -2.01.
How many shares outstanding does Sensorion SAS have?
Sensorion SAS has 10,312,972 shares outstanding.
What happened to Sensorion SAS’s price movement after its last earnings report?
Sensorion SAS reported an EPS of -€2.28 in its last earnings report, missing expectations of -€1.39. Following the earnings report the stock price went down -5.649%.
Which hedge fund is a major shareholder of Sensorion SAS?
Currently, no hedge funds are holding shares in FR:ALSEN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology